Viral hepatitis E in immunosuppressed patients


DOI: https://dx.doi.org/10.18565/therapy.2024.7.88-95

Startseva M.A., Malinnikova E.Yu.

Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia, Moscow
Abstract. Hepatitis E (HE) is one of the most commonly occurred hepatitis. About 20 million cases of viral HE infection are recorded annually, of which 3.3 million are accompanied by clinical manifestations. The severity and form of the disease are determined by various factors, such as age and gender of the patient, changes in premorbid background, also by immune status, presence of pregnancy, and virus genotype. The clinical picture of viral HE is variable – from asymptomatic forms to fulminant and chronic HE. The aim of the review is to analyze the clinical manifestations of viral HE in immunosuppression individuals based on current publications from PubMed, eLibrary, and Scopus databases.
Keywords: hepatitis E, organ transplantation, pregnants, immunosuppressive therapy, HIV
Read entire article

Literature

1. Михайлов М.И., Кюрегян К.К., Малинникова Е.Ю., Поляков А.Д. Гепатит Е, к 40-летию открытия вируса академиком РАМН М.С. Балаяном. Журнал инфектологии. 2021; 13(3): 153–158. (Mikhailov M.I., Kyuregyan K.K., Malinnikova E.Yu., Polyakov A.D. Hepatitis E, to the 40th anniversary of the discovery of the virus by academician of the RAMS M.S. Balayan. Zhurnal infektologii = Journal Infectology. 2021; 13(3):153–158. (In Russ.)).


2. Михайлов М.И., Малинникова Е.Ю., Кюрегян К.К., Поляков А.Д. Гепатит Е – актуальные проблемы изучения (2016–2018). Инфекционные болезни: новости, мнения, обучение. 2019; 8(1): 74–83. (Mikhaylov M.I., Malinnikova E.Yu., Kyuregyan K.K., Polyakov A.D. Hepatitis E – actual research questions (2016–2018). Infektsionnyye bolezni: novosti, mneniya, obucheniye = Infectious Diseases: News, Views, Education. 2019; 8(1): 74–83 (In Russ.)).


https://doi.org/10.24411/2305-34962019-11010. EDN: ZCFEFF.


3. Всемирная организация здравоохранения. Гепатит E. Доступ: https://www.who.int/ru/news-room/fact-sheets/detail/hepatitis-e (дата обращения – 20.09.2024). (World Health Organization. Hepatitis E. URL: https://www.who.int/ru/news-room/fact-sheets/detail/hepatitis-e (date of access – 20.09.2024) (In Russ.)).


4. Willauer A.N., Sherman K.E. Hepatitis E virus: has anything changed? Curr Opin Gastroenterol. 2023; 39(3): 169–174.


https://doi.org/10.1097/MOG.0000000000000918. PMID: 36976855. PMCID: PMC10164061.


5. Letafati A., Taghiabadi Z., Roushanzamir M. et al. From discovery to treatment: Tracing the path of hepatitis E virus. Virol J. 2024; 21(1): 194.


https://doi.org/10.1186/s12985-024-02470-3. PMID: 39180020. PMCID: PMC11342613.


6. Raji Y.E., Toung O.P., Taib N.M., Sekawi Z.B. Hepatitis E Virus: An emerging enigmatic and underestimated pathogen. Saudi J Biol Sci. 2022; 29(1): 499–512.


https://doi.org/10.1016/j.sjbs.2021.09.003. PMID: 35002446. PMCID: PMC8716866.


7. Pisano M.B., Campbell C., Anugwom C. et al. Hepatitis E virus infection in the United States: Seroprevalence, risk factors and the influence of immunological assays. PLoS One. 2022; 17(8): e0272809.


https://doi.org/10.1371/journal.pone.0272809. PMID: 35930611. PMCID: PMC9355204.


8. Dreier J., Knabbe C., Vollmer T. Transfusion-transmitted hepatitis E: NAT screening of blood donations and infectious dose. Front Med (Lausanne). 2018; 5: 5.


https://doi.org/10.3389/fmed.2018.00005. PMID: 29450199. PMCID: PMC5799287.


9. Pishmisheva M., Shikov P., Golkocheva-Markova E. et al. Spread of hepatitis E viral infection among hemodialysis patients in Pazardzhik District, Bulgaria. Int J Curr Microbiol Appl Sci. 2020; 9(1): 1086–92.


https://doi.org/10.20546/ijcmas.2020.901.123.


10. Qian Z., Li T., Zhang Y., Chen S. et al. Prevalence of hepatitis E virus and its association with adverse pregnancy outcomes in pregnant women in China. J Clin Virol. 2023; 158: 105353.


https://doi.org/10.1016/j.jcv.2022.105353. PMID: 36527809.


11. Bigna J.J., Modiyinji A.F., Nansseu J.R. et al. Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: A systematic review and meta-analysis. BMC Pregnancy Childbirth. 2020; 20(1): 426.


https://doi.org/10.1186/s12884-020-03116-2. PMID: 32723309. PMCID: PMC7388479.


12. Affeldt P., Di Cristanziano V., Grundmann F. et al. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation. Immun Inflamm Dis. 2021; 9(2): 513–20.


https://doi.org/10.1002/iid3.411. PMID: 33559399. PMCID: PMC8127542.


13. Gorris M., van der Lecq B.M., van Erpecum K.J., de Bruijne J. Treatment for chronic hepatitis E virus infection: A systematic review and meta-analysis. J Viral Hepat. 2021; 28(3): 454–63.


https://doi.org/10.1111/jvh.13456. PMID: 33301609. PMCID: PMC7898834.


14. Hansrivijit P., Trongtorsak A., Puthenpura M.M. et al. Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis. World J Gastroenterol. 2021; 27(12): 1240–54.


https://doi.org/10.3748/wjg. v27.i12.1240. PMID: 33828397. PMCID: PMC8006097.


15. Малинникова Е.Ю., Кюрегян К.К., Поляков А.Д. с соавт. Вирусный гепатит Е. Современный взгляд на проблему. Медицина экстремальных ситуаций. 2018; 20(3): 293–299. (Malinnikova E.Yu., Kuregyan K.K., Polyakov A.D. et al. Viral hepatitis E. A modern view of the problem. Meditsina ekstremal’nyh situatsij = Medicine of Extreme Situations. 2018; 20(3): 293–299 (In Russ.)). EDN: YBKINF.


16. Каира А.Н., Свитич О.А. Особенности эпидемического процесса вирусных гепатитов А и Е в Российской Федерации. Эпидемиология и вакцинопрофилактика. 2021; 20(5): 69–78. (Kaira A.N., Svitich O.A. Features of the epidemic process of viral hepatitis A and E in the Russian Federation. Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccinal Prevention. 2021; 20(5): 69–78 (In Russ.)).


https://doi.org/10.31631/2073-3046-2021-20-4-69-78. EDN: CZTMYQ.


17. Li P., Liu J., Li Y. et al. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. Liver Int. 2020; 40(7): 1516–28.


https://doi.org/10.1111/liv.14468. PMID: 32281721. PMCID: PMC7384095.


18. Lhomme S., Marion O., Abravanel F. et al. Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. J Clin Med. 2020; 9(2): 331.


https://doi.org/10.3390/jcm9020331. PMID: 31991629. PMCID: PMC7073673.


19. Gouilly J., Chen Q., Siewiera J. et al. Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface. Nat Commun. 2018; 9(1): 4748.


https://doi.org/10.1038/s41467-018-07200-2. PMID: 30420629. PMCID: PMC6232144.


20. Peroni E., Mora P., Motte A. et al. Fatal fulminant hepatitis E in a diabetic patient on metformin. Diagnostics (Basel). 2022; 12(10): 2385.


https://doi.org/10.3390/diagnostics12102385. PMID: 36292073. PMCID: PMC9600022.


21. Harvala H., Reynolds C., Brailsford S., Davison K. Fulminant transfusion-associated hepatitis E virus infection despite screening, England, 2016–2020. Emerg Infect Dis. 2022; 28(9): 1805–13.


https://doi.org/10.3201/eid2809.220487. PMID: 35997399. PMCID: PMC9423923.


22. Ильченко Л.Ю., Малинникова Е.Ю. Фульминантные случаи гепатита Е. Современные проблемы науки и образования. 2014; (2): 313. (Ilchenko L.Yu., Malinnikova E.Yu. Cases of fulminant hepatitis Е. Sovremennye problemy nauki i obrazovaniya = Modern problems of science and education. 2014; (2): 313 (In Russ.)). EDN: SBWGVB.


23. Kosuta I., Ostojic A., Brajkovic A.V. et al. Shifting perspectives in liver diseases after kidney transplantation. World J Hepatol. 2023; 15(7): 883–96.


https://doi.org/10.4254/wjh. v15.i7.883. PMID: 37547033. PMCID: PMC10401415.


24. Choi J.W., Son H.J., Lee S.S. et al. Acute hepatitis E virus superinfection increases mortality in patients with cirrhosis. BMC Infect Dis. 2022; 22(1): 62.


https://doi.org/10.1186/s12879-022-07050-w. PMID: 35042464. PMCID: PMC8767750.


25. Kumar Acharya S., Kumar Sharma P., Singh R. et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007; 46(3): 387–94.


https://doi.org/10.1016/j.jhep.2006.09.016. PMID: 17125878.


26. Ramachandran J., Eapen C.E., Kang G. et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol. 2004; 19(2): 134–38.


https://doi.org/10.1111/j.1440-1746.2004.03188.x. PMID: 14731121.


27. Cheung C.K.M., Wong S.H., Law A.W.H., Law M.F. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol. 2022; 28(1): 47–75.


https://doi.org/10.3748/wjg. v28.i1.47. PMID: 35125819. PMCID: PMC8793017.


28. Pischke S., Peron J.-M., von Wulffen M. et al. Chronic hepatitis E in rheumatology and internal medicine patients: A retrospective multicenter European cohort study. Viruses. 2019; 11(2): 186.


https://doi.org/10.3390/v11020186. PMID: 30813268. PMCID: PMC6410237.


29. Hansrivijit P., Trongtorsak A., Puthenpura M.M. et al. Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis. World J Gastroenterol. 2021; 27(12): 1240–54.


https://doi.org/10.3748/wjg. v27.i12.1240. PMID: 33828397. PMCID: PMC8006097.


30. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018; 68(6): 1256–71.


https://doi.org/10.1016/j.jhep.2018.03.005. PMID: 29609832.


31. Ильченко Л.Ю., Асади Мобархан Ф.А., Карлсен А.А. с соавт. Хронический гепатит Е у пациента с лимфомой Беркитта. Терапия. 2022; 8(3): 109–115. (Ilchenko L.Yu., Asadi Mobarkhan F.A., Karlsen A.A. et al. Chronic hepatitis E in a patient with Burkitt’s lymphoma. Terapiya = Therapy. 2022; 8(3): 109–115 (In Russ.)).


https://dx.doi.org/10.18565/therapy. EDN: TTLHZH.


32. Fousekis F.S., Mitselos I.V., Christodoulou D.K. Extrahepatic manifestations of hepatitis E virus: An overview. Clin Mol Hepatol. 2020; 26(1): 16–23.


https://doi.org/10.3350/cmh.2019.0082. PMID: 31601068. PMCID: PMC6940480.


33. Jha A.K., Kumar G., Dayal V.M. et al. Neurological manifestations of hepatitis E virus infection: An overview. World J Gastroenterol. 2021; 27(18): 2090–2104.


https://doi.org/10.3748/wjg. v27.i18.2090. PMID: 34025066. PMCID: PMC8117739.


34. van Eijk J.J.J., Dalton H.R., Ripellino P. et al. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology. 2017; 89(9): 909–17.


https://doi.org/10.1212/WNL.0000000000004297. PMID: 28768846.


35. Marion O., Abravanel F., Del Bello A. et al. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018; 38(12): 2178–89.


https://doi.org/10.1111/liv.13894. PMID: 29845733.


36. Ciglenecki I., Rumunu J., Wamala J.F. et al. The first reactive vaccination campaign against hepatitis E. Lancet Infect Dis. 2022; 22(8): 1110–11.


https://doi.org/10.1016/S1473-3099(22)00421-2. PMID: 35870452.


About the Autors

Margarita A. Startseva, MD, lecturer at the Department of virology, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia. Address: 125993, Moscow, 2/1, build. 1 Barrikadnaya St.
E-mail: r.schiryaeva@yandex.ru
ORCID: https://orcid.org/0009-0007-2734-8460
Elena Yu. Malinnikova, MD, Dr. Sci. (Medicine), head of the Department of virology, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia. Address: 125993, Moscow, 2/1, build. 1 Barrikadnaya St.
E-mail: virusrmapo@rambler.ru
ORCID: https://orcid.org/0000-0002-5501-5707


Similar Articles

Back to Content

Бионика Медиа